ArticlePloS one2026
Synergistic interfacial engineering of mesoporous magnetic metal oxide TiO2 nanocomposites for sustainable visible-light photocatalysis: Experimental insights and ML-based performance prediction.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigates the structural, optical, morphological, magnetic, and photocatalytic properties of Fe3O4/TiO2 nanocomposites (FeT NCs), synthesized through a modified sol-gel method for the photodegradation of Reactive Yellow 145 (RY145). Characterization of FeT NCs (PL, XRD, FTIR, VSM, DRUV-Vis, DLS, Zeta potential, XPS, BET, SEM, TEM, TGA) revealed that Fe3O4 incorporation into TiO2 enhances charge separation, suppresses electron-hole recombination through Ti-O-Fe linkages, and improves photocatalytic efficiency. The calcined 0.025FeT3 exhibited high crystallinity with dominant anatase TiO2 and no rutile transition. SEM and TEM revealed a core-shell morphology with Fe3O4 cores encapsulated by TiO2, while aggregation was minimized by synthesis conditions. Optimal photocatalytic performance (84.51% % RY145 removal at neutral pH) was achieved using 1 mg mL-1 0.025FeT3 following pseudo-first-order kinetics. The Langmuir-Hinshelwood model yielded rate and equilibrium constants of 2.80 mg.L-1 min-1 and 2.42 L mg-1, respectively. Mechanistic and scavenging experiments indicated that photogenerated holes and •OH radicals dominated the degradation process. The FeT catalyst maintained high stability over six cycles. Magnetic measurements showed soft magnetic behavior with low coercivity and remanence, favoring easy recovery. The reduced bandgap (2.62 eV) facilitated visible-light activation, while BET analysis confirmed a mesoporous structure with high surface area. XPS verified the oxidation states of Fe and Ti, and HPLC confirmed RY145 decomposition via azo bond cleavage and oxidation to carboxylic acids, demonstrating efficient and sustainable photocatalytic activity. 0.025FeT3 demonstrated efficient, stable, and magnetically retrievable photocatalytic activity under visible light, highlighting its potential for sustainable treatment of textile wastewater. To optimize the batch experimental data, a novel ML-driven predictive framework was tested to model and map the relationships between the selected optimization parameters (FeT contents, FeT dose, reaction time), to predict RY145 photodegradation efficiency, and to identify the optimal operating window for improved photocatalytic performance (using three regression measures R2, MAE, and RMSE). The CNN models outperformed with a predicted accuracy and R2 value of 0.91. Based on the results, ML-based evaluation outperformed manual optimization and traditional statistical methods, delivering a more efficient and reliable way for process optimization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.